Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL3347579

Ic1ccccc1.O=S(=O)(O)C(F)(F)F

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 3/20 0.42
TSHR P16473 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA5A P35218 1/20 0.39
CA9 Q16790 1/20 0.39
CES1 P23141 2/20 0.37
ALDH1A1 P00352 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PTPN6 P29350 1/20 0.35
PTPN11 Q06124 1/20 0.35
TPMT P51580 1/20 0.34
MMP1 P03956 1/20 0.34
MMP2 P08253 1/20 0.34
MMP9 P14780 1/20 0.34
MMP8 P22894 1/20 0.34
MMP13 P45452 1/20 0.34
GPR3 P46089 1/20 0.34
HSD11B1 P28845 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL9421901 0.96 PTPN1 (0.40) PTPN1TSHRSMN1; SMN2CA1CA2
Trifluoromethanesulfonic Acid SCHEMBL9421894 0.96 PTPN1 (0.40) PTPN1TSHRSMN1; SMN2CA1CA2
Trifluoromethanesulfonic Acid SCHEMBL9421896 0.96 PTPN1 (0.40) PTPN1TSHRSMN1; SMN2CA1CA2
Trifluoromethanesulfonic Acid SCHEMBL9421914 0.96 PTPN1 (0.40) PTPN1TSHRSMN1; SMN2CA1CA2
Trifluoromethanesulfonic Acid SCHEMBL1310706 0.94 HSD11B1 (0.39) PTPN1TSHRSMN1; SMN2CA1CA2
Trifluoromethanesulfonic Acid SCHEMBL9421917 0.90 TSHR (0.39) PTPN1TSHRSMN1; SMN2CA1CA2
Trifluoromethanesulfonic Acid SCHEMBL28750655 0.88 CA1 (0.43) PTPN1CA1CA2CA9ALDH1A1
Trifluoromethanesulfonic Acid SCHEMBL27707915 0.88 PTPN1 (0.53) PTPN1CA1CA2CA9MMP1
Iodobenzene SCHEMBL28336854 0.83 TSHR (0.46) PTPN1TSHRSMN1; SMN2CA1CA2
Iodobenzene SCHEMBL5815075 0.83 SMN1; SMN2 (0.50) PTPN1TSHRSMN1; SMN2CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112175182-A Positive photosensitive polyesteramide resin and composition using same 明士(北京)新材料开发有限公司 2021-01-05 CN claimed
EP-3741392-A1 POSITRON EMISSION TOMOGRAPHY RADIOTRACER FOR DISEASES ASSOCIATED WITH TRANSLOCATOR PROTEIN OVEREXPRESSION, TRANSLOCATOR PROTEIN-TARGETING LIGAND FOR FLUORESCENCE IMAGING DIAGNOSIS AND PHOTODYNAMIC THERAPY, AND PREPARATION METHOD THEREFOR Seoul National University R & DB Foundation (KR) 2020-11-25 EP claimed
CN-111954543-A Positron emission tomography radioactive tracer for translocator overexpression related diseases, translocator targeting ligand for fluorescence imaging diagnosis and photodynamic therapy and preparation method thereof 首尔国立大学校产学协力财团 2020-11-17 CN claimed
US-20200345870-A1 POSITRON EMISSION TOMOGRAPHY RADIOTRACER FOR DISEASES ASSOCIATED WITH TRANSLOCATOR PROTEIN OVEREXPRESSION, TRANSLOCATOR PROTEIN-TARGETING LIGAND FOR FLUORESCENCE IMAGING-GUIDED SURGERY AND PHOTODYNAMIC THERAPY, AND PRODUCTION METHODS THEREFOR SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) 2020-11-05 US claimed
CN-102037409-B Orthogonal processing of organic materials used in electronic and electrical devices UNIV CORNELL 2013-12-11 CN claimed
CN-102037409-A Orthogonal processing of organic materials used in electronic and electrical devices UNIV CORNELL 2011-04-27 CN claimed
EP-3808750-B1 TRIAZOLINEDIONE ADDUCT, METHOD FOR PRODUCING TRIAZOLINEDIONE ADDUCT, METHOD FOR PRODUCING ENE COMPOUND, AND METHOD FOR ANALYZING ENE COMPOUND TOKUYAMA CORP (JP) 2026-04-01 EP disclosed
US-20260071353-A1 SUBSTRATES, PEPTIDE ARRAYS, AND METHODS VIBRANT HOLDINGS LLC (US) 2026-03-12 US disclosed
US-20260061083-A1 POSITRON EMISSION TOMOGRAPHY RADIOTRACER FOR DISEASES ASSOCIATED WITH TRANSLOCATOR PROTEIN OVEREXPRESSION, TRANSLOCATOR PROTEIN-TARGETING LIGAND FOR FLUORESCENCE IMAGING-GUIDED SURGERY AND PHOTODYNAMIC THERAPY, AND PRODUCTION METHODS THEREFOR SEOUL NATIONAL UNIVERSITY R&DB FOUNDATGON (KR) 2026-03-05 US disclosed
US-12491271-B2 Positron emission tomography radiotracer for diseases associated with translocator protein overexpression, translocator protein-targeting ligand for fluorescence imaging-guided surgery and photodynamic therapy, and production methods therefor SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) 2025-12-09 US disclosed
US-12454771-B2 Substrates, peptide arrays, and methods VIBRANT HOLDINGS LLC (US) 2025-10-28 US disclosed
CN-119395943-A Photosensitive composition and application thereof 江苏艾森半导体材料股份有限公司 2025-02-07 CN disclosed
CN-119179233-A Photosensitive composition, method for producing pattern, cured product, and electronic component 江苏艾森半导体材料股份有限公司 2024-12-24 CN disclosed
EP-1840650-B1 Positive type radiation-sensitive resin composition JSR CORP (JP) 2009-03-18 EP disclosed
EP-1840650-A1 Positive type radiation-sensitive resin composition JSR Corporation (JP) 2007-10-03 EP disclosed
CN-1645253-A Photosensitive resin composition, photosensitive element using the same, method for producing resist pattern and method for producing printed wiring board HITACHI CHEMICAL CO LTD (JP) 2005-07-27 CN disclosed
CN-1209685-C Photosensitive resin composition, photosensitive element using the same, method for producing protective layer pattern, and method for producing printed wiring board HITACHI CHEMICAL CO LTD (JP) 2005-07-06 CN disclosed
CN-1418329-A Photosensitive resin composition, photosensitive element using the same, method for producing protective layer pattern, and method for producing printed wiring board HITACHI CHEMICAL CO LTD (JP) 2003-05-14 CN disclosed
EP-0284868-B1 Photoresist compositions MICROSI INC (US) 1995-05-03 EP disclosed
EP-0284868-A2 Photoresist compositions MicroSi, Inc. (a Delaware corporation) (US) 1988-10-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260071353-A1 SUBSTRATES, PEPTIDE ARRAYS, AND METHODS VIP, CALCB, SPPL2B PTPN1 1568/4885TSHR 810/4885SMN1; SMN2 1108/4885
US-20260061083-A1 POSITRON EMISSION TOMOGRAPHY RADIOTRACER FOR DISEASES ASSOCIATED WITH TRANSLOCATOR PROTEIN OVEREXPRESSION, TRANSLOCATOR PROTEIN-TARGETING LIGAND FOR FLUORESCENCE IMAGING-GUIDED SURGERY AND PHOTODYNAMIC THERAPY, AND PRODUCTION METHODS THEREFOR TSPO, FABP7, SLC46A1 PTPN1 4231/4885TSHR 1026/4885SMN1; SMN2 1360/4885
US-12491271-B2 Positron emission tomography radiotracer for diseases associated with translocator protein overexpression, translocator protein-targeting ligand for fluorescence imaging-guided surgery and photodynamic therapy, and production methods therefor TSPO, FABP7, SLC46A1 PTPN1 4411/4885TSHR 2480/4885SMN1; SMN2 2420/4885
US-20200345870-A1 POSITRON EMISSION TOMOGRAPHY RADIOTRACER FOR DISEASES ASSOCIATED WITH TRANSLOCATOR PROTEIN OVEREXPRESSION, TRANSLOCATOR PROTEIN-TARGETING LIGAND FOR FLUORESCENCE IMAGING-GUIDED SURGERY AND PHOTODYNAMIC THERAPY, AND PRODUCTION METHODS THEREFOR TSPO, TMEM14C, FABP7 PTPN1 3233/4885TSHR 1084/4885SMN1; SMN2 1600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.